Table 2.
Physical activity, energy and several other food components intakes and their differences in the placebo and soy isoflavone groups at the baseline and at the end of the study.
| Variables | Groups | Baseline | After 12 weeks | Changes (%) | P valuea |
|---|---|---|---|---|---|
| Physical activity (MET.h.d) | Soy isoflavone | 38.0 ± 5.57 | 39.94 ± 9.95 | 1.94 ± 9.75 | 0.329 |
| Placebo | 34.27 ± 9.32 | 36.77 ± 6.76 | 2.50 ± 8.21 | 0.179 | |
| P valueb | 0.101 | 0.223 | 0.836 | ||
| Total energy intake (kcal/day) | Soy isoflavone | 2082.30 ± 707.19 | 1981.44 ± 538.58 | − 100.85 ± 783.37 | 0.526 |
| Placebo | 2111.23 ± 694.58 | 1984.72 ± 1108.32 | − 126.50 ± 1235.43 | 0.644 | |
| P valueb | 0.890 | 0.990 | 0.932 | ||
| Total carbohydrates (g/day) | Soy isoflavone | 233.30 ± 106.29 | 240.71 ± 88.30 | 7.40 ± 129.36 | 0.777 |
| Placebo | 261.72 ± 74.39 | 246.50 ± 146.78 | − 15.22 ± 138.36 | 0.620 | |
| P valueb | 0.308 | 0.870 | 0.570 | ||
| Total protein (g/day) | Soy isoflavone | 74.71 ± 25.64 | 73.64 ± 18.62 | − 1.07 ± 25.04 | 0.832 |
| Placebo | 87.38 ± 41.95 | 90.72 ± 48.50 | 3.34 ± 59.31 | 0.799 | |
| P valueb | 0.215 | 0.140 | 0.753 | ||
| Total fat (g/day) | Soy isoflavone | 99.30 ± 34.82 | 85.46 ± 19.71 | − 13.83 ± 36.09 | 0.067 |
| Placebo | 107.05 ± 60.10 | 93.46 ± 30.12 | − 13.59 ± 68.62 | 0.375 | |
| P valueb | 0.588 | 0.285 | 0.988 | ||
| Cholesterol (mg/day) | Soy isoflavone | 286.46 ± 182.51 | 219.94 ± 71.11 | − 66.51 ± 175.48 | 0.070 |
| Placebo | 238.18 ± 142.47 | 216.06 ± 184.52 | − 22.11 ± 177.29 | 0.574 | |
| P valueb | 0.330 | 0.928 | 0.40 | ||
| Fiber (g/day) | Soy isoflavone | 27.61 ± 18.48 | 33.26 ± 22.55 | 5.65 ± 25.18 | 0.273 |
| Placebo | 27.43 ± 11.04 | 30.36 ± 25.12 | 2.93 ± 24.13 | 0.584 | |
| P valueb | 0.968 | 0.683 | 0.712 | ||
| SFA (g/day) | Soy isoflavone | 21.08 ± 6.60 | 20.10 ± 6.04 | − 0.98 ± 7.54 | 0.522 |
| Placebo | 21.88 ± 6.38 | 20.94 ± 7.30 | − 0.94 ± 7.39 | 0.566 | |
| P valueb | 0.681 | 0.672 | 0.985 | ||
| MUFA (g/day) | Soy isoflavone | 38.97 ± 14.16 | 33.07 ± 7.58 | − 5.89 ± 14.41 | 0.052 |
| Placebo | 37.03 ± 10.52 | 34.84 ± 11.40 | − 2.19 ± 14.85 | 0.506 | |
| P valueb | 0.608 | 0.534 | 0.397 | ||
| PUFA w-3 (g/day) | Soy isoflavone | 0.85 ± 0.48 | 0.69 ± 0.29 | − 0.15 ± 0.53 | 0.152 |
| Placebo | 0.66 ± 0.47 | 0.66 ± 0.47 | 0.002 ± 0.59 | 0.986 | |
| P valueb | 0.182 | 0.802 | 0.338 | ||
| PUFA w-6 (g/day) | Soy isoflavone | 10.57 ± 4.88 | 8.53 ± 2.54 | − 2.03 ± 4.34 | 0.028 |
| Placebo | 9.56 ± 4.01 | 8.31 ± 3.91 | − 1.25 ± 6.02 | 0.350 | |
| P valueb | 0.457 | 0.817 | 0.614 | ||
| Vitamin C (mg/day) | Soy isoflavone | 100.05 ± 99.49 | 102.59 ± 50.78 | 2.53 ± 101.45 | 0.901 |
| Placebo | 122.94 ± 69.98 | 129.79 ± 71.87 | 6.85 ± 82.41 | 0.707 | |
| P valueb | 0.381 | 0.141 | 0.877 | ||
| Vitamin E (mg/day) | Soy isoflavone | 37.73 ± 16.76 | 30.68 ± 8.56 | − 7.05 ± 15.14 | 0.029 |
| Placebo | 35.82 ± 11.40 | 31.92 ± 10.21 | − 3.90 ± 15.39 | 0.259 | |
| P valueb | 0.660 | 0.657 | 0.489 | ||
| Selenium (mg/day) | Soy isoflavone | 103.73 ± 58.27 | 102.90 ± 38.64 | − 0.82 ± 55.52 | 0.941 |
| Placebo | 110.61 ± 48.68 | 113.68 ± 95.39 | 0.57 ± 24.80 | 0.904 | |
| P valueb | 0.607 | 0.669 | 0.882 | ||
| Zinc (mg/day) | Soy isoflavone | 10.80 ± 3.90 | 11.23 ± 3.37 | 0.42 ± 4.15 | 0.617 |
| Placebo | 16.20 ± 19.84 | 16.77 ± 14.50 | 0.57 ± 24.80 | 0.917 | |
| P valueb | 0.190 | 0.101 | 0.978 |
All the variables demonstrated as mean ± SD.
Significant values are in [bold].
SFA saturated fatty acids, MUFA mono unsaturated fatty acids, PUFA poly unsaturated fatty acids.
aP value attained from paired sample t-test.
bP value based on independent sample t-test.